Learn More
Medchemexpress LLC Zeteletinib (BOS-172738; DS-5010) | 2216753-97-6 | 98.3% | 500.47 | 50 MG

Supplier: Medchemexpress LLC HY13959050MG
Zeteletinib is an orally active, selective RET kinase inhibitor. It exhibits nanomolar potency against RET and demonstrates over 300-fold selectivity against VEGFR2, showing potent antitumor activity.
- Highly potent against wild-type RET.
- Effective against RETV804M/L gatekeeper mutants.
- Targets the common oncogenic RET mutation M918T.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.